Omevil D Capsule is a combination pharmaceutical formulation containing Domperidone 10mg and Omeprazole 20mg, designed to manage gastrointestinal disorders effectively. Domperidone, a dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing symptomatic relief and promoting healing in acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The synergistic action of these two agents makes Omevil D Capsule particularly effective in treating conditions where both acid suppression and enhanced gastric motility are required. It is indicated for the management of gastroesophageal reflux symptoms, dyspepsia, and other acid-peptic disorders accompanied by delayed gastric emptying. The medication should be taken as prescribed by a healthcare professional, with consideration of contraindications such as known hypersensitivity to either component, and caution in patients with underlying cardiac conditions due to Domperidone’s potential to prolong the QT interval. Regular monitoring and adherence to dosage instructions are essential to ensure therapeutic efficacy and minimize adverse effects.